Decrease in human immunodeficiency virus antigen titer in the cerebrospinal fluid during treatment of AIDS patients with zidovudine
Claasen, J.N.
Nederlands Tijdschrift Voor Geneeskunde 132(46): 2122-2123
1988
ISSN/ISBN: 0028-2162 PMID: 3205324 Document Number: 315579
Document emailed within 1 workday
Related Documents
Katz, R.L.; Alappattu, C.; Glass, J.P.; Bruner, J.M. 1989: Cerebrospinal fluid manifestations of the neurologic complications of human immunodeficiency virus infection Acta Cytologica 33(2): 233-244Franke, M.F.; Stulac, S.N.; Rugira, I.H.; Rich, M.L.; Bucyibaruta, J.B.; Drobac, P.C.; Iyamungu, G.; Bryant, C.M.; Binagwaho, A.; Farmer, P.E.; Mukherjee, J.S. 2011: High human immunodeficiency virus-free survival of infants born to human immunodeficiency virus-positive mothers in an integrated program to decrease child mortality in rural Rwanda Pediatric Infectious Disease Journal 30(7): 614-616
Henry, D.H.; Beall, G.N.; Benson, C.A.; Carey, J.; Cone, L.A.; Eron, L.J.; Fiala, M.; Fischl, M.A.; Gabin, S.J.; Gottlieb, M.S. 1992: Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials Annals of Internal Medicine 117(9): 739-748
Kidangazhiayathmana, A. 2011: Is Kerala remaining low prevalent in human immunodeficiency virus by accident? a study of risk factors in acquiring human immunodeficiency virus infection in patients attending Anti-retroviral treatment clinic Indian Journal of Dermatology Venereology and Leprology 77(6): 729
Marlier, S.; De Jaureguiberry, J.P.; Drouet, A.; Muzellec, Y.; Jaubert, D. 1994: Early reappearance of varicella-zona virus in the cerebrospinal fluid after treatment with foscarnet in AIDS Presse Medicale 23(34): 1583
Podzamczer, D.; Barros, C.; Berenguer, J.; Gutiérrez, Félix.; Iribarren, Jé.Antonio.; Miró, Jé.M.; Molina, Jé.Pérez.; Podzamczer, D.; Aguirrebengoa, K.; Arribas, Jé.Ramón.; Boix, V.; Cahn, P.; Castro, A.; Caylá, J.; Cobo, J.; Corzo, J.Enrique.; de la Torre, J.; Dronda, F.; Ena, J.; Falcó, Vç.; Ferrer, E.; Labarga, P.; Locutura, J.; Mallolas, J.; Moreno, S.; Ocampo, A.; Ocaña, Ján.; Padilla, Bén.; Elías, Jús.Pérez.; Polo, R.; Portilla, Jín.; Riera, M.; Rivero, A.; Salavert, M.; Sanz, Jé. 2008: Treatment of opportunistic infections in adolescent and adult patients infected with the human immunodeficiency virus during the era of highly active antiretroviral therapy. AIDS Study Group (GESIDA) and National AIDS Plan Expert Committee Enfermedades Infecciosas y Microbiologia Clinica 26(6): 356-379
Budhachandra, Y.; Ramesh, K.; Sumitra, G. 2007: Personality profile among Human Immunodeficiency Virus (HIV) positives and Acquired Immunodeficiency Syndrome (AIDS) patients of injecting drug users Kathmandu University Medical Journal 5(1): 38-41
1990: Report on zidovudine use in asymptomatic human immunodeficiency virus infection published Clinical Pharmacy 9(6): 406 408
Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94
Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51
Diaz, A.; Ten, A.; Marcos, H.; Gutiérrez, G.; González-García, J.; Moreno, S.; Barrios, A.M.ía.; Arponen, S.; Portillo, Ál.; Serrano, R.; García, M.T.; Pérez, J.é L.; Toledo, J.; Royo, M.C.; González, G.; Izquierdo, A.; Viloria, L.J.; López, I.; Elizalde, L.áz.; Martínez, E.; Castrillejo, D.; Aranguren, R.; Redondo, C.; Diez, M. 2015: Factors determining irregular attendance to follow-up visits among human immunodeficiency virus patients: results of the hospital survey of patients infected with human immunodeficiency virus Enfermedades Infecciosas y Microbiologia Clinica 33(5): 324-330
Pachón, J.; Viciana, P.; Cisneros, J.M.; García Pesquera, F.; Castillo, J.R.; Cañas, E. 1993: Pharmacokinetic study of zidovudine in parenteral drug addicts with human immunodeficiency virus infection Medicina Clinica 100(2): 46-49
Tagami, T. 1970: Disc electrophoretic analysis of cerebrospinal fluid proteins in the disturbances of optic nerve. I. Comparison of cerebrospinal fluid at various sites in the cerebrospinal axis. With special reference to the cerebrospinal fluid in the chiasmatic cistern Nippon Ganka Gakkai Zasshi 74(9): 1129-1135
Richman, D.D.; Grimes, J.M.; Lagakos, S.W. 1990: Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus Journal of Acquired Immune Deficiency Syndromes 3(8): 743-746
Baillou, A.; Barin, F.; Allain, J.P.; Petat, E.; Kocheleff, P.; Kadende, P.; Goudeau, A. 1987: Human immunodeficiency virus antigenemia in patients with AIDS and AIDS-related disorders: a comparison between European and Central African populations Journal of Infectious Diseases 156(5): 830-833
Crumpacker, C.; Heagy, W.; Bubley, G.; Monroe, J.E.; Finberg, R.; Hussey, S.; Schnipper, L.; Lucey, D.; Lee, T.H.; McLane, M.F. 1987: Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation Annals of Internal Medicine 107(5): 664-674
Pivert, A.; Payan, C.; Lunel, F.; C, E.R.T. A. 2004: Comparaison des cinétiques de l'ARN et de l'antigène de capside du virus de l'hépatite C dans le suivi thérapeutique des patients co-infectés par le virus de l'hépatite C et le virus de l'immunodéficience humaine, traités par bithérapie interféron-ribavirine, dans le cadre du protocole RIBAVIC - Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol Pathologie et Biologie 52(9): 522-528
Iroezindu, M.O.; Daniyam, C.A.; Agbaji, O.O.; Isa, E.S.; Okeke, E.N.; Imade, G.E. 2013: Prevalence of hepatitis B e antigen among human immunodeficiency virus and hepatitis B virus co-infected patients in Jos, Nigeria Journal of Infection in Developing Countries 7(12): 951-959
D'Agaro, P.; Andrian, P.; Roscioli, B.; Mascioli, M.; Dal Molin, G.; Comar, M.; Faruzzo, A.; Majori, L. 1990: HIV-1 isolation and p24-antigen detection in cerebrospinal fluid of subjects with neurological abnormalities related to AIDS Acta Neurologica 12(1): 49-52
Wen, Y.; Guan, J.; Wu, Z.; Li, L.; Rotheram-Borus, M.Jane.; Lin, C.; Detels, R. 2009: Pharmacy workers' sexually transmitted diseases/human immunodeficiency virus knowledge in Fuzhou, China: implications for human immunodeficiency virus testing, treatment, and prevention strategies Sexually Transmitted Diseases 36(4): 221-226